Ranta-Ylikulju, Jenni

English

UEF Electronic Publications

[Article in Spanish] Ginecol Obstet Mex.

[Multivariate analysis of risk factors with placental abruption in preeclampsia]. [Article in Chinese] Zhonghua Fu Chan Ke Za Zhi.

20. doi: 10.1002/uog.11095. [Epub ahead of print] Khalil A, Pajkrt E, Chitty LS. Early prenatal diagnosis of skeletal anomalies. Prenat Diagn.

3rd, Conover CA. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.

A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beeta-hCG and PAPP-A.

A meta-analysis of low-dose aspirin for prevention of preeclampsia. J Postgrad Med.

A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol.

A simple, efficient and inexpensive program for preventing prematurity.

A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod.

Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr.

Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn

Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol.

Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and metaanalysis. J Obstet Gynaecol Can.

Acute stimulation of human chorionic gonadotropin secretion by recombinant human activin-A in first trimester human trophoblast. Endocrinology.

ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn.

Adjustment of serum markers in first trimester screening.

Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther.

American Congress of Obstetricians and Gynecologists practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33. Obstet Gynecol.

An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

Antifetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol.

Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestationalage newborns. Birth Defects Res B Dev Reprod Toxicol.

Appropriate biochemical parameters in first-trimester screening for Down syndrome. Prenat Diagn.

Authority for Health and Welfare. Termination of pregnancy. 2012 (In Finnish). Available at: http://www.valvira.fi/luvat/raskauden_ keskeyttaminen.

Available at: http://www.epshp.fi/files/55/ Palveluhinnasto_2012.pdf. Accessed

Available at: http://www.fetalmedicine.com/fmf/FMF-English.pdf. Accessed Feb 12,

Available at: http://www.stakes.fi/verkkojulkaisut/Muut/op34_1999.pdf. Accessed

Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol.

Calculated risk of chromosomal abnormalities in twin gestations. Obstet Gynecol.

Characteristics of hypertension in pregnancy. A retrospective study of 261 consecutive cases. Acta Obstet Gynecol Scand Suppl.

Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin North Am.

Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem.

Chromosomal mosaicism in human preimplantation embryos: a systematic review. Hum Reprod Update.

Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome. Hum Reprod.

Chronic hypertension in pregnancy. Curr Opin Obstet Gynecol.

Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol.

Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol.

CLARICOR Trial Group. Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis.

Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. BJOG.

Confined placental mosaicism and intrauterine growth retardation: a case-control analysis of placentas at delivery. Am J Obstet Gynecol.

Congenital anomalies 1993–2008, Statistical report. National Institute for Health and Welfare

Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Utrasound Obstet Gynecol 1998;11:388-400. South Ostrobothnia Central Hospital District (Etelä-Pohjanmaan sairaanhoitopiiri).

Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.

Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancyassociated plasma protein-A. J Endocrinol.

Disseminated intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost.

Donnenfeld AE; ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med.

Down's syndrome and the gastrointestinal tract. J Clin Gastroenterol.

Downin oireyhtymän seulonta Suomessa.

Early first-trimester free- -hCG and PAPPA serum distributions in monochorionic and dichorionic twins. Prenat Diagn.

Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab.

Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn.

Effect of a new marker, ADAM12, on Down risk figures in first trimester screening. J Matern Fetal Neonatal Med.

Etude des chromosomes somatiques de neuf enfants mongoliens&quot;.

Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med.

Finnish acts and decrees. Law on pregnancy abortion (In Finnish)

Finnish acts and decrees. National Health Law.

Finnish Government Decree on Screenings.

Finnish Ministry of Social Welfare and Health. The group of specialists memorandum.

First trimester fetal nuchal translucency: problems with screening the general population. 2. Br J Obstet Gynaecol.

First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18.

First trimester predictors of adverse pregnancy outcomes.

First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. Fertil Steril.

First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn.

First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol.

First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol.

First-trimester diagnosis of body stalk anomaly using 2- and 3-dimensional sonography. J Ultrasound Med.

First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Am J Obstet Gynecol.

First-trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol.

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol.

First-trimester or second-trimester screening, or both, for Down's syndrome.

First-trimester prediction of hypertensive disorders in pregnancy. Hypertension.

First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency. Ultrasound Obstet Gynecol.

First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod.

First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol.

Firsttrimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat Diagn.

Firsttrimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol.

for Health and Welfare

Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers. Ann Clin Biochem.

Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can.

Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol.

Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn.

Increased fetal nuchal translucency thickness at 10-14 weeks: is screening for maternal-fetal infection necessary? Br J Obstet Gynaecol.

Increased nuchal translucency as a marker for fetal chromosomal defects.

Influence of age on risk-factors during pregnancy, delivery and puerperium of primiparae (author's transl)]. [Article in German] Geburtshilfe Frauenheilkd.

Late sequelae of induced abortion: complications and outcome of pregnancy and labor.

Learning curve in ultrasonographic screening for selected fetal structural anomalies in early pregnancy. Obstet Gynecol.

Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation. Ultrasound Obstet Gynecol.

Low maternal serum level of pregnancy associated plasma protein (PAPP-A) in the first trimester in association with abnormal fetal karyotype.

Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.

Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol.

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (hellp syndrome)

Maternal obesity and pregnancy outcome: a prospective analysis. J Assoc Physicians India.

Maternal serum 25-hydroxyvitamin D concentrations are 39 associated with small-for-gestational age births in white

Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.

Maternal serum free alpha- and free beta- human chorionic gonadotropin in pregnancies with insulin-depedendent diabetes mellitus: implications for screening for Down’s syndrome. Prenat Diagn

Maternal serum screening for Down's syndrome in early pregnancy. BMJ.

Maternal serumalpha- fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of the U.K. collaborative study on alpha-fetoprotein in relation to neural- tube defects.

Measurement of pregnancy-associated plasma proteins during human gestation. J Clin Invest.

Miten Down-seulontaa parannetaan (In Finnish). Lääketieteellinen Aikakauskirja Duodecim

First trimester Down\u92s syndrome screening The role of biochemistry

http://epublications.uef.fi/pub/urn_isbn_978-952-61-0770-7/urn_isbn_978-952-61-0770-7.pdf

First trimester Down\u92s syndrome screening The role of biochemistry

Abstract

Similar works

Full text

Available Versions

UEF Electronic Publications